Sepracor Sees Reward In Lunesta Promotion Push
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor credits its intensive marketing sales and education programs as the key to new prescription growth in the third quarter despite the recent entry of two competing sleep aids.